US 11628215
HIV vaccines comprising one or more population episensus antigens
granted A61KA61K2039/53A61K2039/70
Quick answer
US patent 11628215 (HIV vaccines comprising one or more population episensus antigens) held by Vir Biotechnology, Inc. expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vir Biotechnology, Inc.
- Grant date
- Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K39/21